Intervention Study to Increase Smoking Cessation Rates Among Public Housing Residents
NCT ID: NCT01651611
Last Updated: 2016-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
330 participants
INTERVENTIONAL
2011-09-30
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations
NCT01156610
Smoking Cessation Intervention in Public Housing
NCT01035151
Enhancing Equity in Smoke-free Housing
NCT06042361
Comparing Population Cessation Services
NCT01566994
Motivation and Nicotine Patch Treatment for Under-served Smokers
NCT01684995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Extensive TTA interaction
Persons interested in quitting smoking will receive multiple in-person visits from a peer Tobacco Treatment Advocate (TTA) who will provide motivational interviewing, basic smoking cessation counseling assistance, navigation to smoking cessation resources, and social support.
Motivational interviewing
The TTA will use motivational interviewing (MI) techniques to assess the participant's motivation and readiness to quit, suggest plans, and assist the participant in selecting a method of treatment.
Smoking cessation counseling
The TTA will provide information to the participant regarding evidence-based treatments for smoking cessation, including counseling and nicotine replacement therapy (NRT); assist in a quit plan; and discuss issues such as obtaining social support, staying in treatment, and dealing with lapses.
Navigation to smoking cessation resources
The TTA will assist participants in obtaining NRT and getting connected to smoking cessation counseling services, such as the Smokers' Quitline and clinic-based programs.
Social support
Meetings with the TTA will be a source of social support for the participant as they attempt to quit or stay quit.
Minimal TTA interaction
Persons interested in quitting smoking will receive a single in-person visit from a peer Tobacco Treatment Advocate (TTA) who will provide basic smoking cessation counseling assistance.
Smoking cessation counseling
The TTA will provide information to the participant regarding evidence-based treatments for smoking cessation, including counseling and nicotine replacement therapy (NRT); assist in a quit plan; and discuss issues such as obtaining social support, staying in treatment, and dealing with lapses.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motivational interviewing
The TTA will use motivational interviewing (MI) techniques to assess the participant's motivation and readiness to quit, suggest plans, and assist the participant in selecting a method of treatment.
Smoking cessation counseling
The TTA will provide information to the participant regarding evidence-based treatments for smoking cessation, including counseling and nicotine replacement therapy (NRT); assist in a quit plan; and discuss issues such as obtaining social support, staying in treatment, and dealing with lapses.
Navigation to smoking cessation resources
The TTA will assist participants in obtaining NRT and getting connected to smoking cessation counseling services, such as the Smokers' Quitline and clinic-based programs.
Social support
Meetings with the TTA will be a source of social support for the participant as they attempt to quit or stay quit.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Housing Sites: Sites are eligible for the study if they have 50+ smokers determined by synthetic estimates based on citywide survey data.
* Age 18-79
* Current everyday or someday smokers
* Planning to quit smoking in 30 days or thinking about quitting in next 6 months,
* Have smoked 100 cigarettes in lifetime
* Speak English or Spanish
* Plan to live in Public Housing for next 12 months
* Able and willing to provide consent
Exclusion Criteria
* Unable to communicate orally in English or Spanish.
* Currently using pharmacological treatment for smoking cessation
* Currently working with the Smokers Quitline or other Community Health Center based cessation program
* Cognitive/ psychiatric conditions that would interfere with ability to understand and participate in the study
* Have been abstinent for 7 or more days.
18 Years
79 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Harvard School of Public Health (HSPH)
OTHER
The Miriam Hospital
OTHER
Boston Housing Authority
UNKNOWN
Boston University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel R Brooks, DSc
Role: PRINCIPAL_INVESTIGATOR
Boston University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston University School of Public Health
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-28386
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.